Results

Total Results: 3,111 records

Showing results for "risks".

  1. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/description-of-a-question-or-questions-about-a-health-care-test-or-treatment-o-in-women-with-leiomyomas-who-are-candidates-for-surgery-does-the-use-of-adjunctive-medical-treatment-result-in-better-outcomes-preoperative-adjuv
    November 01, 2017 - (Preoperative adjuvants & intraoperative adjuvants) What are the risks and benefits to expectant management … What are the risks and benefits of morcellation used as part of laparoscopic myomectomy or hysterectomy … Benefits: As alternatives to hysterectomy become increasingly available, the efficacies and risks of … Obstetricians and gynecologists continually focus on providing the best medical care at the lowest risk … vaginal or laparoscopic hysterectomy, are preferred because they reduce a patient's overall operative risk
  2. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-
    November 01, 2017 - have priority so as women can be accurately diagnosed without unnecessary further invasive testing and risks … Improvement in accurately diagnosing CAD in women to improve overall mortality and risks associated with … Describe any health-related risks, side effects, or harms that you are concerned about. … This guideline states that assessing a woman's pre-CAD risk is what the practitioner should use in determining … This guideline states that assessing a woman's pre-CAD risk is what the practitioner should use in determining
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - 2: Do specifics of OC use (e.g., dose/formulation, age at initiation, duration of use) affect the relative … age, family history of breast and ovarian cancer, BRCA1/BRCA2 mutation status, parity) affect the relative … and relative risk (or relative risk reduction) for that outcome in OC users to generate estimates of … risk. … Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
  4. effectivehealthcare-admin.ahrq.gov/products/breast-reconstruction-mastectomy/research
    March 01, 2022 - The risks of seroma or of unplanned repeat surgery for revision probably are comparable with or without … Risk of bias was moderate to high for most studies. … SoE) and may pose a greater risk of breast seroma (low SoE). … well-being, and patient satisfaction with breasts (all low SoE), and probably results in comparable risks … Whether or not ADM is used probably is associated with comparable risks of seroma and unplanned repeat
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mental-health-mobile-apps-disposition-of-comments.pdf
    May 20, 2022 - We agree that the risk of the app should stand separately, and it does in the framework. … prevent individuals from benefitting from app use, but we do want to provide an assessment of the risks … Currently, only Section 1 “Risk and Mitigation Strategies” is scored. … This places patients and providers at risk by technology companies. … We also support AHRQ’s approach with respect to risk and the requirement for evidence and, for high-risk
  6. effectivehealthcare-admin.ahrq.gov/products/antipsychotic-medicine-mortality-elderly/research
    November 01, 2017 - Evidence is growing that conventiona lantipsychotic medication (APM )use maybe associated with greater risks … or atypical APM (1996 – 2004) Measurements Cox proportional hazards models were used to compare risks … Initiators of conventional APMs also had a higher risk for death due to respiratory diseases, nervous … Conclusions These data suggest that increased risk of CV deaths might explai nabout half of the excess … The risk of death due to respiratory causes was also significantly higher in conventional APM use.
  7. effectivehealthcare-admin.ahrq.gov/products/mental-health-apps/report
    October 01, 2022 - Stakeholders in Technology Evaluation for Recovery (FASTER) to Mental Health and Wellness assesses the risk … Our review of the existing frameworks identified gaps in the assessment of risks that users may face … Risks and Mitigation Strategies, assesses the integrity and risk profile of the app; Section 2.
  8. effectivehealthcare-admin.ahrq.gov/products/cesarean-birth-future/research
    December 01, 2019 - collection of data on maternal and infant outcomes (category B), and understanding how patients perceive risk … and how best to communicate risk of mode of delivery after prior cesarean (category C). … With regard to category C, stakeholders prioritized research about how patients perceive the risks of … trial of labor (TOL) compared with repeat cesarean delivery, how best to frame and communicate the risks
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic … Evidence Report Disposition of Comments Report Research Review Title: The Effectiveness and Risks … The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. … For studies that did not report relative measures of effects, we calculated relative risks when data … You can cite the limitations, but at least you will have summarized for readers a range of risks and
  10. effectivehealthcare-admin.ahrq.gov/products/mhs4-opioid-stewardship/protocol
    September 01, 2023 - However, opioids also carry well known risks, including for overdose, misuse, and opioid use disorder … tapering of opioids causing withdrawal, distress, and suicidal ideation. 3 Thus, any approach to mitigate risks … The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. … Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription … The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
    January 01, 2012 - difference and relative risk and is an information- preserving approach. … If reviewers only presented the relative risk, it would not be possible to obtain the risk difference … along with 39 relative risks. 9 Systematic reviewers should conduct the quantitative assessment … Additive Risk versus Additive Relative Risk Models. Epidemiology. 1993; 4:32- 6. 29. … Using alternative statistical formats for presenting risks and risk reductions.
  12. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-wome
    November 01, 2017 - or in conjunction with one another, provide the highest rate of disease management with the lowest risk … or in conjunction with one another, provide the highest rate of disease management with the lowest risk … Particularly, to better understand which treatment options should be used to reduce the risk of further … Describe any health-related risks, side effects, or harms that you are concerned about. … I have been advised that the greatest risks associated with Biologic treatment arise when one goes off
  13. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/peripheral-artery-disease-pad-defined-as-peripheral-artery-disease-of-the-lower-extremities-1-does-aspirin-reduce-the-risk-of-adverse-cardiovascular-events-mi-stroke-cardiovascular-death-in-patients-with-pad-is-there-a-diffe
    November 01, 2017 - Disease (PAD) - defined as peripheral artery disease of the lower extremities 1) Does aspirin reduce the risk … ) defined as peripheral artery disease of the lower extremities Does aspirin reduce the risk … Improvements in mortality and morbidity and quality of life Describe any health-related risks, side … Bleeding risks associated with anti-platelet therapy in patients with PAD and co-morbid disease … It is associated with a 5 fold increased risk of adverse cardiovascular events.
  14. effectivehealthcare-admin.ahrq.gov/health-topics/environmental-health
    November 20, 2024 - Some environmental risks are a part of the natural world, like radon in the soil.
  15. effectivehealthcare-admin.ahrq.gov/health-topics/assisted-living?page=0
    May 30, 2017 - in Dementia Systematic Review Archived September 29, 2014 The Effectiveness and Risks … Chronic Pain Research Protocol Archived December 19, 2013 The Effectiveness and Risks
  16. effectivehealthcare-admin.ahrq.gov/health-topics/neurologic-diseases?page=1
    December 03, 2015 - Disabilities Systematic Review Archived September 29, 2014 The Effectiveness and Risks … Effectiveness Research Protocol Archived December 19, 2013 The Effectiveness and Risks
  17. effectivehealthcare-admin.ahrq.gov/health-topics/pain?page=1
    April 14, 2016 - Low Back Pain Systematic Review Archived September 29, 2014 The Effectiveness and Risks … Effectiveness Research Protocol Archived December 19, 2013 The Effectiveness and Risks
  18. effectivehealthcare-admin.ahrq.gov/health-topics/assisted-living
    May 30, 2017 - in Dementia Systematic Review Archived September 29, 2014 The Effectiveness and Risks … Chronic Pain Research Protocol Archived December 19, 2013 The Effectiveness and Risks
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
    April 01, 2013 - mortality and MACE in studies of 365 days or longer, we saw no significant difference in mortality risk … not significantly impact the achievement of ST-segment resolution, prevention of no reflow, or the risk … Do Not Know Conclusion #1 In the catheter aspiration trials, the risks of major adverse cardiovascular … mortality and MACE in studies of 365 days or longer, we saw no significant difference in mortality risk … not significantly impact the achievement of ST-segment resolution, prevention of no reflow, or the risk
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
    January 01, 2020 - Long-term risks are not directly related to short term outcomes. … .adjusted odd ratios (aORs) of 1.75 relative to the mean cohort glucose values...' 1.75-fold is a relative … gain are more/equally important for adverse outcomes and clinicians do not rely on isolated OGTT relativerisks or odd ratios but on women individual multifactorial absolute risks. … Research indicates that IGT and GDM carry similar risks of adverse outcomes.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: